Northern Light Venture Capital
Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2022
Nutshell Therapeutics completes $40 million Series A+ funding
Nutshell Therapeutics announced that it had completed a $40 million Series A+ financing. Yuansheng Capital led the round, with Hengxu Capital co-leading and existing investors also participating.
2021
NGGT completes $30 million Series A financing
NGGT announced that it had completed a $30 million Series A financing led by Yipu Capital, with Weidu Capital and existing investors also participating. The proceeds are intended for clinical-product preparation across its gene-therapy pipeline and construction of a cGMP production workshop.
2021
Denglin Technology completes Series A+ funding
Denglin Technology completed a Series A+ funding round led jointly by Yuanhe Puhua and Yuansheng Capital, with existing shareholders including Northern Light Venture Capital also investing.